Introduction of the gene editing tool #SATI by Salk Institute to treat diseases caused by gene mutations, created a stir within the #Biotech industry.
#Socialmedia went into overdrive when the news of the #medical breakthrough poured in. The social community was #psyched about new #research outcome. Our analysis showed that people from different walks of life were commenting on the story.
People were thrilled to know that the tool can edit the #genome when #mutations are at work. Industry experts commented on the procedure of genome editing in #gene mutation diseases like Huntington’s disease and Progeria, a rare premature aging syndrome. #Scientists and #researchers also actively shared this study result on social media.
People Engaging On Social Media
Some individuals commented that this invention could replace the #drugs and would not have any side effects. While some were wary about the efficacy of the tool in fighting genetic syndromes and raised an outcry about the ethical issues that might be caused due to genome editing.
The top interests of social media users discussing this news were mainly technology, books, and science.
Interest Analysis of Active Social Media Users
SATI (Single homology Arm donor mediated Intro-Targeting Integration) is built on HITI, a CRISPR-Cas9 gene editing technique variant that deals with mutations by inserting a healthy copy of the #troublesome gene into a region of DNA that does not involve coding. This way the function of the gene will not be impacted.
The Salk Institute team first applied the tool on mice that showed signs of premature aging. The application of the tool diminished the aging in tissues like skin and spleen. It further extended the life span by approximately 45%. When considered in human life years, this extension can mean the addition of more than a decade.
The genetic modifications, made possible by the tool, can make selective genetic mutation diseases a thing of the past. The integration of #advanced #biomedical matrices together with transformational #technology has enabled this pathbreaking #innovation.
#Biotech, as an #academic episteme, has thrived the most in the 21st century. It has not only eased out the treatment of various diseases but also expedited the diagnosis of a whole spectrum of disease. The impact of biotechnology in future prognosis cannot be undermined.
Now, this tool has opened up a gamut of opportunities for biotech giants. While the actual use of the tool is still being debated, it is already being viewed as a transformational innovation. It has the capacity to change how #medical and biotech industries approach gene mutation diseases.
The tool will further improve our understanding of DNA and gene mutation. The Salk Institute team is now looking to further investigate the cellular systems that are involved in DNA repair. Like any other biotech innovation, there is still more work to be done. There will be a few more clinical trials and their results will be closely monitored. But if all goes well, the #healthcare industry will have a new way of mitigating mutation-based diseases.